Commit To Purchase Reata Pharmaceuticals At $75, Earn 26.7% Annualized Using Options
March 27, 2019 at 11:50 AM EDT
Investors eyeing a purchase of Reata Pharmaceuticals Inc (RETA) stock, but tentative about paying the going market price of $85.61/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $75 strike, which has a bid at the time of this writing of $14.70..